Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection

Herpes simplex virus 1 (HSV-1) is a widely distributed virus. HSV-1 is a growing public health concern due to the emergence of drug-resistant strains and the current lack of a clinically specific drug for treatment. In recent years, increasing attention has been paid to the development of peptide an...

Full description

Bibliographic Details
Main Authors: Xiaomin Guo, Yanxing An, Wanmin Tan, Ling Ma, Mingyang Wang, Juyan Li, Binghong Li, Wei Hou, Li Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1201505/full
_version_ 1797772660021657600
author Xiaomin Guo
Yanxing An
Wanmin Tan
Ling Ma
Mingyang Wang
Juyan Li
Binghong Li
Wei Hou
Li Wu
author_facet Xiaomin Guo
Yanxing An
Wanmin Tan
Ling Ma
Mingyang Wang
Juyan Li
Binghong Li
Wei Hou
Li Wu
author_sort Xiaomin Guo
collection DOAJ
description Herpes simplex virus 1 (HSV-1) is a widely distributed virus. HSV-1 is a growing public health concern due to the emergence of drug-resistant strains and the current lack of a clinically specific drug for treatment. In recent years, increasing attention has been paid to the development of peptide antivirals. Natural host-defense peptides which have uniquely evolved to protect the host have been reported to have antiviral properties. Cathelicidins are a family of multi-functional antimicrobial peptides found in almost all vertebrate species and play a vital role in the immune system. In this study, we demonstrated the anti-HSV-1 effect of an antiviral peptide named WL-1 derived from human cathelicidin. We found that WL-1 inhibited HSV-1 infection in epithelial and neuronal cells. Furthermore, the administration of WL-1 improved the survival rate and reduced viral load and inflammation during HSV-1 infection via ocular scarification. Moreover, facial nerve dysfunction, involving the abnormal blink reflex, nose position, and vibrissae movement, and pathological injury were prevented when HSV-1 ear inoculation-infected mice were treated with WL-1. Together, our findings demonstrate that WL-1 may be a potential novel antiviral agent against HSV-1 infection-induced facial palsy.
first_indexed 2024-03-12T21:55:10Z
format Article
id doaj.art-731e4e44841145cebda99ef79c4d6fd6
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-03-12T21:55:10Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-731e4e44841145cebda99ef79c4d6fd62023-07-25T18:02:50ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2023-06-011410.3389/fmicb.2023.12015051201505Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infectionXiaomin Guo0Yanxing An1Wanmin Tan2Ling Ma3Mingyang Wang4Juyan Li5Binghong Li6Wei Hou7Li Wu8College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, ChinaCollege of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, ChinaDepartment of Medical Imaging, First Affiliated Hospital of Kunming Medical University, Kunming, ChinaDepartment of Medical Imaging, First Affiliated Hospital of Kunming Medical University, Kunming, ChinaDepartment of Medical Imaging, First Affiliated Hospital of Kunming Medical University, Kunming, ChinaDepartment of Medical Imaging, First Affiliated Hospital of Kunming Medical University, Kunming, ChinaDepartment of Medical Imaging, First Affiliated Hospital of Kunming Medical University, Kunming, ChinaCollege of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, ChinaDepartment of Medical Imaging, First Affiliated Hospital of Kunming Medical University, Kunming, ChinaHerpes simplex virus 1 (HSV-1) is a widely distributed virus. HSV-1 is a growing public health concern due to the emergence of drug-resistant strains and the current lack of a clinically specific drug for treatment. In recent years, increasing attention has been paid to the development of peptide antivirals. Natural host-defense peptides which have uniquely evolved to protect the host have been reported to have antiviral properties. Cathelicidins are a family of multi-functional antimicrobial peptides found in almost all vertebrate species and play a vital role in the immune system. In this study, we demonstrated the anti-HSV-1 effect of an antiviral peptide named WL-1 derived from human cathelicidin. We found that WL-1 inhibited HSV-1 infection in epithelial and neuronal cells. Furthermore, the administration of WL-1 improved the survival rate and reduced viral load and inflammation during HSV-1 infection via ocular scarification. Moreover, facial nerve dysfunction, involving the abnormal blink reflex, nose position, and vibrissae movement, and pathological injury were prevented when HSV-1 ear inoculation-infected mice were treated with WL-1. Together, our findings demonstrate that WL-1 may be a potential novel antiviral agent against HSV-1 infection-induced facial palsy.https://www.frontiersin.org/articles/10.3389/fmicb.2023.1201505/fullcathelicidinsantiviral peptideHSV-1facial palsyWL-1
spellingShingle Xiaomin Guo
Yanxing An
Wanmin Tan
Ling Ma
Mingyang Wang
Juyan Li
Binghong Li
Wei Hou
Li Wu
Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection
Frontiers in Microbiology
cathelicidins
antiviral peptide
HSV-1
facial palsy
WL-1
title Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection
title_full Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection
title_fullStr Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection
title_full_unstemmed Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection
title_short Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection
title_sort cathelicidin derived antiviral peptide inhibits herpes simplex virus 1 infection
topic cathelicidins
antiviral peptide
HSV-1
facial palsy
WL-1
url https://www.frontiersin.org/articles/10.3389/fmicb.2023.1201505/full
work_keys_str_mv AT xiaominguo cathelicidinderivedantiviralpeptideinhibitsherpessimplexvirus1infection
AT yanxingan cathelicidinderivedantiviralpeptideinhibitsherpessimplexvirus1infection
AT wanmintan cathelicidinderivedantiviralpeptideinhibitsherpessimplexvirus1infection
AT lingma cathelicidinderivedantiviralpeptideinhibitsherpessimplexvirus1infection
AT mingyangwang cathelicidinderivedantiviralpeptideinhibitsherpessimplexvirus1infection
AT juyanli cathelicidinderivedantiviralpeptideinhibitsherpessimplexvirus1infection
AT binghongli cathelicidinderivedantiviralpeptideinhibitsherpessimplexvirus1infection
AT weihou cathelicidinderivedantiviralpeptideinhibitsherpessimplexvirus1infection
AT liwu cathelicidinderivedantiviralpeptideinhibitsherpessimplexvirus1infection